Читать книгу The Peripheral T-Cell Lymphomas - Группа авторов - Страница 9

Aadil Ahmed Department of Hematology, Yale University School of Medicine, New Haven, CT, USA

Stephen M. Ansell Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

James O. Armitage Division of Oncology‐Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

N. Nora Bennani Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

Govind Bhagat Division of Hematopathology, Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA

Alessandro Broccoli IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, Bologna, Italia

HeeJin Cheon Department of Medicine & Biochemistry and Molecular Genetics, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Monica Civallero Department of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

Paolo Corradini Fondazione IRCCS istituto Nazionale dei Tumori, Milano, Italy; and University of Milano, Italy

Sandeep Dave Duke Cancer Institute, Center for Genomic and Computational Biology, Duke University, Durham, NC, USA

Laurence de Leval Institut de Pathologie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland

Claire Dearden Department of Haematology, The Royal Marsden NHS Foundation Trust, Sutton, UK

Anna Dodero Fondazione IRCCS istituto Nazionale dei Tumori, Milano, Italy; and University of Milano, Italy

Jehan Dupuis Lymphoid Malignancies Unit, Henri Mondor University Hospital, Créteil, France

Karolina H. Dziewulska Department of Medicine and Department of Pathology, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Dima El‐Sharkawi Department of Haematology, The Royal Marsden NHS Foundation Trust, Sutton, UK

Leonardo José Enciso‐Olivera Programa de Investigación e Innovación en Leucemias Agudas y Crónicas (PILAC) Instituto Nacional de Cancerología, Bogotá, Colombia

Massimo Federico Department of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

David J. Feith Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Andrew L. Feldman Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Francine Foss Department of Hematology, Yale University School of Medicine, New Haven, CT, USA

Philippe Gaulard Assistance Publique des Hôpitaux de Paris, Paris, France; Institut Mondor de Recherche Biomédicale, INSERMU955, Université Paris Est Créteil, Créteil, France; and Département de Pathologie, Hôpitaux Universitaires Henri Mondor, Créteil, France

Alejandro A. Gru Department of Pathology and Dermatology, University of Virginia, Charlottesville, VA, USA

Sean Harrop Epworth Healthcare and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Keiichiro Hattori Department of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan

Eliza Hawke Department of Oncology and Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia

Tyler A. Herek Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Henry Idrobo‐Quintero Grupo Latinoamericano de estudio de Linfoproliferativos (GELL) Hospital Universitario del Valle, Grupo Ospedale, Universidad del Valle, Universidad Libre, Cali, Colombia.

Javeed Iqbal Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Arnaud Jaccard Service d’Hématologie et de Thérapie Cellulaire, Hôpital Dupuytren, CHU de Limoges, Limoges, France

Elaine S. Jaffe Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, MD, USA

Salvia Jain Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA, and Harvard Medical School, Boston, MA, USA

Avyakta Kallam Division of Oncology‐Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

Seok Jin Kim Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea

Won Seog Kim Division of Hematology and Oncology,Sungkyunkwan University School of Medicine,Samsung Medical Center,Seoul, Korea

Raphael Koch Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany

Jianping Kong Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Iryna Kriachok Oncohematology Department, National Cancer Institute, Kyiv, Ukraine

Manabu Kusakabe Department of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan, and Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

François Lemonnier Unité hémopathies Lymphoïdes, Hôpitaux Universitaires Henri Mondor, Créteil, France; Assistance Publique des Hôpitaux de Paris, Paris, France; and Institut Mondor de Recherche Biomédicale, INSERMU955, Université Paris Est Créteil, Créteil, France

Soon Thye Lim Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

Thomas P. Loughran, Jr Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Helen Ma Department of Medicine, Division of Hematology and Oncology, Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Martina Manni Department of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

Enrica Marchi University of Virginia Cancer Center, Charlottesville, VA, USA

Rolando Humberto Martinez‐Cordero Instituto Nacional de Cancerología, Universidad El Bosque, Bogotá, Colombia

Mwanasha Merrill Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA

Kevin Molloy Department of Dermatology, University Hospital, Birmingham, UK

Francesca Montanari Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Katharine B. Moosic Department of Medicine and Department of Pathology, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Franck Morschhauser Department of Hematology, Lille University Hospital, Lille, France

Wataru Munakata Department of Hematology, National Cancer Center Hospital, Tokyo, Japan

Owen A. O’Connor Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA, and Program for T‐Cell Lymphoma Research, Department of Microbiology, Immunology and Cancer Research University of Virginia Cancer Center, Charlottesville, VA, USA

Kristine C. Olson Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA

Juan Alejandro Ospina‐Idárraga Los Cobos Medical Center, Instituto Nacional de Cancerología, Universidad El Bosque, Bogotá, Colombia

Neval Ozkaya Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, MD, USA

Pier Paolo Piccaluga Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy

Stefano A. Pileri Hematopathology Division, European Institute of Oncology, IRCCS, Milan, Italy

H. Miles Prince Epworth Healthcare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia

Barbara Pro Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA

Dejan Radjeski Sir Charles Gardner Hospital, Perth, Western Australia, Australia

Bethanie Rooke Department of Dermatology, University Hospital, Birmingham, UK

Tatsuhiro Sakamoto Department of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan, and Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

Mamiko Sakata‐Yanagimoto Department of Hematology, Faculty of Medicine, University of Tsukuba Hospital, Tsukuba, Japan, and Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

Ahmed Sawas Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Julia Scarisbrick Department of Dermatology, University Hospital, Birmingham, UK

Luigi Scotto Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA

Jennifer Shingleton Duke Cancer Institute, Center for Genomic and Computational Biology, Duke University, Durham, NC, USA

Raksha Shrestha Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

Andrei Shustov Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; and Seattle Cancer Care Alliance, Seattle, WA, USA

Tetiana Skrypets Department of Surgical, Medical and Dental Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy

Craig R. Soderquist Division of Hematopathology, Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA

Robert N. Stuver Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA

Ritsuro Suzuki Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan

Kensei Tobinai Department of Hematology, National Cancer Center Hospital, Tokyo, Japan

Claudio Tripodo Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy, and Histopathology Unit, FIRC Institute of Molecular Oncology, Milan, Italy

Lorenz Truempe Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany

Sean Whittaker Guy’s and St Thomas’ National Health Service Foundation Trust, London, UK

Mina Xu Department Pathology, Yale University School of Medicine, New Haven, CT, USA

Amulya Yellala Division of Oncology‐Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

Anas Younes Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Jasmine Zain Department of Hematology/Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA

Pier Luigi Zinzani IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, Bologna, Italia